STOCK TITAN

Vir Biotechnology to Participate in the 22nd Annual Needham Virtual Healthcare Conference

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

Vir Biotechnology announced that Dr. Phil Pang, its Chief Medical Officer, will participate in a fireside chat during the 22nd Annual Needham Virtual Healthcare Conference on April 18, 2023, at 12:00 p.m. PT / 3:00 p.m. ET.

Investors can access a live webcast of the presentation in the Investors section of the Vir website, which will also be archived for 30 days.

Vir Biotechnology is dedicated to treating and preventing serious infectious diseases by leveraging innovative technologies and immunologic insights. Their development pipeline includes candidates targeting COVID-19, hepatitis B and D, influenza A, and HIV.

Positive
  • None.
Negative
  • None.

SAN FRANCISCO, April 11, 2023 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that Phil Pang, M.D., Ph.D., Executive Vice President, Chief Medical Officer and Interim Head of Research, is scheduled to participate in a fireside chat at the 22nd Annual Needham Virtual Healthcare Conference on Tuesday, April 18, at 12:00 p.m. PT / 3:00 p.m. ET.

A live webcast of the presentation can be accessed under Events & Presentations in the Investors section of the Vir website at www.vir.bio and will be archived there for 30 days.

About Vir Biotechnology
Vir Biotechnology is a commercial-stage immunology company focused on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. Vir has assembled four technology platforms that are designed to stimulate and enhance the immune system by exploiting critical observations of natural immune processes. Its current development pipeline consists of product candidates targeting COVID-19, hepatitis B and D viruses, influenza A and human immunodeficiency virus. Vir routinely posts information that may be important to investors on its website.


FAQ

What is the schedule for Vir Biotechnology's event on April 18, 2023?

Dr. Phil Pang will participate in a fireside chat at 12:00 p.m. PT / 3:00 p.m. ET during the 22nd Annual Needham Virtual Healthcare Conference.

Where can I watch the Vir Biotechnology webcast?

The live webcast of the presentation can be accessed under Events & Presentations in the Investors section of the Vir website.

How long will the Vir Biotechnology webcast be available?

The webcast will be archived on the Vir website for 30 days after the event.

What diseases does Vir Biotechnology focus on?

Vir Biotechnology focuses on treating and preventing serious infectious diseases like COVID-19, hepatitis B and D, influenza A, and HIV.

Who is the Chief Medical Officer of Vir Biotechnology?

The Chief Medical Officer of Vir Biotechnology is Dr. Phil Pang.

Vir Biotechnology, Inc.

NASDAQ:VIR

VIR Rankings

VIR Latest News

VIR Stock Data

1.72B
117.08M
11.9%
74.31%
4.42%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States of America
SAN FRANCISCO